CUOMO, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 1.463
AS - Asia 1.200
NA - Nord America 846
SA - Sud America 153
AF - Africa 58
OC - Oceania 2
Totale 3.722
Nazione #
US - Stati Uniti d'America 812
SG - Singapore 643
IT - Italia 602
RU - Federazione Russa 479
CN - Cina 265
BR - Brasile 117
DE - Germania 116
VN - Vietnam 86
HK - Hong Kong 83
FR - Francia 40
NL - Olanda 37
GB - Regno Unito 31
JP - Giappone 27
IN - India 26
FI - Finlandia 25
CA - Canada 20
PT - Portogallo 19
ES - Italia 18
AR - Argentina 16
PL - Polonia 15
KR - Corea 14
ZA - Sudafrica 14
CI - Costa d'Avorio 13
AT - Austria 12
LT - Lituania 12
MX - Messico 10
BE - Belgio 8
CO - Colombia 8
EG - Egitto 8
TR - Turchia 8
UA - Ucraina 8
MA - Marocco 7
BD - Bangladesh 6
PK - Pakistan 6
SE - Svezia 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
IE - Irlanda 5
IQ - Iraq 5
AE - Emirati Arabi Uniti 4
GE - Georgia 4
HR - Croazia 4
KE - Kenya 4
RO - Romania 4
UZ - Uzbekistan 4
VE - Venezuela 4
CH - Svizzera 3
EC - Ecuador 3
PH - Filippine 3
RS - Serbia 3
TN - Tunisia 3
BJ - Benin 2
GR - Grecia 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GF - Guiana Francese 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
SD - Sudan 1
SI - Slovenia 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
YE - Yemen 1
YT - Mayotte 1
Totale 3.722
Città #
Singapore 316
Moscow 128
Ashburn 118
Chandler 116
Hefei 84
Hong Kong 82
Naples 82
Beijing 73
Santa Clara 44
Munich 35
Ho Chi Minh City 33
Milan 28
Rome 28
Los Angeles 25
Millbury 21
Palermo 20
Lawrence 19
Dallas 18
Amsterdam 17
Frankfurt am Main 16
New York 16
Buffalo 15
San Jose 15
Seattle 15
Bologna 14
Napoli 14
Seoul 14
Boston 12
Caserta 12
Des Moines 12
Helsinki 11
São Paulo 11
Tokyo 11
London 10
Montijo 10
Redondo Beach 10
Turin 10
Bari 9
Hanoi 9
Nanjing 9
Orem 9
Sennori 9
Wilmington 9
Council Bluffs 8
Manfredonia 8
Toronto 8
Bogotá 7
Denver 7
Düsseldorf 7
Falkenstein 7
Houston 7
Kochi 7
Nuremberg 7
Turku 7
Woodbridge 7
Brescia 6
Catania 6
Foggia 6
Johannesburg 6
Madrid 6
Padova 6
Warsaw 6
Brooklyn 5
Cagliari 5
Castelcovati 5
Chengdu 5
Chennai 5
Collecchio 5
Montreal 5
Roubaix 5
Vienna 5
Wroclaw 5
Belo Horizonte 4
Cologne 4
Dong Ket 4
Fairfield 4
Florence 4
Guangzhou 4
Lappeenranta 4
Locorotondo 4
Mexico City 4
Nairobi 4
Oeiras 4
Olomouc 4
Ottawa 4
Piemonte 4
Pune 4
Stockholm 4
The Dalles 4
Thái Bình 4
Vilnius 4
Zagreb 4
Ankara 3
Atlanta 3
Betim 3
Buenos Aires 3
Casablanca 3
Castel Rozzone 3
Chiyoda-ku 3
Haiphong 3
Totale 1.852
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 694
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia 141
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 124
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 119
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients 118
New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension 117
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 113
Oxidative stress in anticancer therapies-related cardiac dysfunction 113
Prevention of cardiovascular complications in elderly cancer patients 113
Editorial: Myocardium regeneration and cardioprotection 107
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 105
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 105
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 104
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 104
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 103
Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula? 102
The broad spectrum of cardiotoxicities from immunotherapies 99
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 98
Cardiovascular events and treatment of children with high risk medulloblastoma 98
Commentary on “Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is not Related to Improvement in Left Ventricular Ejection Fraction” 95
Electrical Storm in Patients with Inappropriate Implantable Cardioverter-Defibrillator Therapy: Current Trends in Clinical Practice between Guidelines and Technology Progress 95
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 87
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 87
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 84
Prevention of cancer-therapy-related heart failure 80
Causes and outcomes of {ICU} hospitalisations in patients with pulmonary arterial hypertension 76
Pembrolizumab associated hypereosinophilia in locally advanced triple-negative breast cancer 76
Cardio-Oncology Challenges in Elderly Patients 74
Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances 71
Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography 70
Is it time to update our defibrillation strategies for refractory ventricular fibrillation? 63
Inflammation at the crossroad between cancer and heart failure 55
Virtual reality solution to promote adapted physical activity in older adults: outcomes from VR2Care project exploratory study 23
TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension 19
Digital interventions addressing the unmet needs of older adults with multimorbidity: a mixed-methods persona design approach 16
Nonpharmacological management of pulmonary arterial hypertension 15
The Activin Pathway in Chronic Thromboembolic Pulmonary Hypertension: A Potential Biomarker for Residual Pulmonary Hypertension After Endarterectomy 11
Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy 9
ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly 8
Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome 7
Totale 3.798
Categoria #
all - tutte 12.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 16 1 7 16 3 5
2021/2022144 6 0 0 8 2 5 11 8 3 16 41 44
2022/2023597 21 34 41 46 59 43 45 86 124 53 25 20
2023/2024340 19 20 33 39 22 52 20 42 17 20 32 24
2024/20251.216 49 44 6 28 28 110 109 100 73 113 429 127
2025/20261.359 213 173 277 187 412 85 12 0 0 0 0 0
Totale 3.798